UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 213

Sortiert nach

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1631-1641

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

JNCI : Journal of the National Cancer Institute, 2016-04, Vol.108 (4), p.djv362

2016

Link zum Volltext

Verfügbarkeit prüfen

Richter syndrome: Biology, incidence, and therapeutic strategies

Cancer, 2005-01, Vol.103 (2), p.216-228

2005

Link zum Volltext

Verfügbarkeit prüfen

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations

Journal of clinical oncology, 2012-03, Vol.30 (8), p.777-782

2012

Link zum Volltext

Verfügbarkeit prüfen

A decision support framework for genomically informed investigational cancer therapy

JNCI : Journal of the National Cancer Institute, 2015-07, Vol.107 (7), p.1

2015

Link zum Volltext

Verfügbarkeit prüfen

Overview of precision oncology trials: challenges and opportunities

Expert review of clinical pharmacology, 2018-08, Vol.11 (8), p.797-804

2018

Link zum Volltext

Verfügbarkeit prüfen

Health policy: Strategies to optimize expedited investigational new drug safety reports

Nature reviews. Clinical oncology, 2016-04, Vol.13 (4), p.207

Tsimberidou, Apostolia M

2016

Link zum Volltext

Verfügbarkeit prüfen

Treatment of fludarabine‐refractory chronic lymphocytic leukemia

Cancer, 2009-07, Vol.115 (13), p.2824-2836

2009

Link zum Volltext

Verfügbarkeit prüfen

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Journal of clinical oncology, 2009-02, Vol.27 (6), p.904-910

2009

Link zum Volltext

Verfügbarkeit prüfen

Myeloid sarcoma is associated with superior event‐free survival and overall survival compared with acute myeloid leukemia

Cancer, 2008-09, Vol.113 (6), p.1370-1378

2008

Link zum Volltext

Verfügbarkeit prüfen

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia

Cancer, 2009-01, Vol.115 (2), p.373-380

2009

Link zum Volltext

Verfügbarkeit prüfen

Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6243-6250

2009

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Journal of clinical oncology, 2023-03, Vol.41 (9), p.1725-1734

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non–small-cell Lung Cancer

Clinical lung cancer, 2020-11, Vol.21 (6), p.477-481

2020

Link zum Volltext

Verfügbarkeit prüfen

Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study

Investigational new drugs, 2022-02, Vol.40 (1), p.124-133

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation

Journal of clinical oncology, 2006-05, Vol.24 (15), p.2343-2351

2006

Link zum Volltext

Verfügbarkeit prüfen

Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer

Investigational new drugs, 2015-06, Vol.33 (3), p.621-631

2015

Link zum Volltext

Verfügbarkeit prüfen

Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early‐phase oncology clinical trials

Cancer, 2016-11, Vol.122 (21), p.3401-3409

2016

Link zum Volltext

Verfügbarkeit prüfen

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement

Journal of clinical oncology, 2019-01, Vol.37 (1), p.72-80

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients With Richter's Syndrome or Fludarabine-Refractory Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2008-01, Vol.26 (2), p.196-203

2008

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin transformation of chronic lymphocytic leukemia : The M. D. anderson cancer center experience

Cancer, 2006-09, Vol.107 (6), p.1294-1302

2006

Link zum Volltext

Verfügbarkeit prüfen

Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center

Cancer, 2012-03, Vol.118 (5), p.1422-1428

2012

Link zum Volltext

Verfügbarkeit prüfen

Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1582-1589

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 213

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(202)

Publikationsform

Artikel
(213)

Sprache

Englisch
(213)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Humans
(81)
Life Sciences & Biomedicine
(81)
Science & Technology
(81)
Oncology
(74)
Female
(52)
Middle Aged
(52)
Male
(48)
Adult
(47)
Aged
(45)
Biological And Medical Sciences
(37)
Medical Sciences
(37)
Tumors
(37)
Treatment Outcome
(31)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Aged, 80 And Over
(26)
Neoplasms - Drug Therapy
(20)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(19)
Pharmacology & Pharmacy
(19)
Hematologic And Hematopoietic Diseases
(18)
Medicine
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

Richter syndrome: Biology, incidence, and therapeutic strategies

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations

A decision support framework for genomically informed investigational cancer therapy

Overview of precision oncology trials: challenges and opportunities

Health policy: Strategies to optimize expedited investigational new drug safety reports

Treatment of fludarabine‐refractory chronic lymphocytic leukemia

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Myeloid sarcoma is associated with superior event‐free survival and overall survival compared with acute myeloid leukemia

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia

Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non–small-cell Lung Cancer

Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study

Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation

Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer

Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early‐phase oncology clinical trials

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement

Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients With Richter's Syndrome or Fludarabine-Refractory Chronic Lymphocytic Leukemia

Hodgkin transformation of chronic lymphocytic leukemia : The M. D. anderson cancer center experience

Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center

Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

Aktive Filter

Suchergebnisse filtern